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Abstract
In the present study, we compared the effects of endothelin (ET)-1 on cell proliferation and second messenger induction in
normal rat kidney (NRK) fibroblasts, with those of other activators of G-protein-coupled receptors such as prostaglandin
(PG)-F2K, bradykinin (BK), and lysophosphatidic acid (LPA). LPA is mitogenic by itself, while the other factors require the
presence of EGF. In density-arrested NRK cells, ET-1 and LPA induce phenotypic transformation rapidly, with similar
kinetics as retinoic acid (RA) and transforming growth factor (TGF)-L, while BK and PGF2K only do so with delayed
kinetics. ET-1 and PGF2K are strong inducers of anchorage-independent growth, with a similar level of induction as TGFL,
in contrast to LPA and BK. When investigating the second messenger generation, we found that ET-1 is the strongest
activator of arachidonic acid release and phosphatidylinositol diphosphate hydrolysis. Only in the case of ET-1 the cell
depolarization is not reversible upon removal of the factor. Similarly, only the ET-1-induced transient enhancement of
intracellular calcium concentration is paralleled by both homologous and heterologous desensitization. In conclusion, these
data show that ET-1 is a potent inducer of second messengers and phenotypic transformation in NRK cells, with
characteristics that clearly differ from those of other activators of G-protein-coupled receptors, most likely as a result of
prolonged receptor activation. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Endothelin-1 (ET-1) has originally been identi¢ed
as a potent vasoconstrictor synthesized by endothe-
lial cells, but later studies have indicated that it has a
wide range of additional physiological and patho-
physiological activities (for reviews see [1^3]). ET-1
belongs to a family of 21-amino-acid peptides that
bind to receptors that belong to the seven transmem-
brane domain superfamily of G-protein-coupled re-
ceptors, designated the ETA and ETB receptors. De-
pending on the cell type studied, ET-1 has been
described to activate Gq resulting in activation of
phospholipase C [4^7], to activate Gi leading to in-
hibition of adenylate cyclase [4,8,9] or to activate Gs
thereby activating adenylate cyclase [10]. Moreover,
it has been shown that ET-1 is able to increase pro-
tein tyrosine kinase activity [11^13], and to activate
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the phospholipases A2 [1] and D [5,7] as well as
ERK1 and ERK2 [11,14].
With respect to cell proliferation, both positive
[4,5,12] and negative [15] e¡ects of ET-1 have been
described. Also in the case of normal rat kidney
(NRK) cells, ET-1 has been shown to have growth
modulating activity [16,17]. In these cells ET-1
mainly binds to the ETA receptor [18], resulting in
an increase in [Ca2]i [17,19], the degradation of in-
ositol-containing phospholipids [19], the expression
of c-jun, jun B, and c-fos mRNA in a time-dependent
manner, and an upregulation of EGF (epidermal
growth factor) receptor density [18]. Recent data
have shown that ET-1 is also able to induce anchor-
age-independent growth of NRK cells in an EGF-
dependent manner [17].
NRK cells are immortalized ¢broblasts that have
widely been used as a model system for studying
growth factor-induced phenotypic transformation,
including loss of density-dependent growth control
and induction of anchorage-independent growth.
We have postulated [20] that NRK cells become den-
sity-arrested when cultured in the presence of EGF
as the only growth-stimulating factor, because above
a speci¢c cell density the number of EGF receptors
drops below the critical level that is required for
EGF-induced growth stimulation. Proliferation can
be restored by addition of parallel-acting growth fac-
tors such as platelet-derived growth factor (PDGF)
resulting in phenotypic transformation. Alterna-
tively, growth regulating stimuli such as transforming
growth factor L (TGFL) or retinoic acid (RA) can be
added, which by themselves have no growth-stimu-
lating activity for NRK cells, but are able to enhance
EGF receptor levels, making these density-arrested
cells responsive again to EGF.
In recent studies we have shown that also a num-
ber of ligands for G-protein-coupled receptors (for
reviews see [21^23]), including prostaglandin F2K
(PGF2K), bradykinin (BK), and lysophosphatidic
acid (LPA) are able to induce phenotypic transfor-
mation of NRK cells in an EGF-dependent manner
[24,25]. Interestingly, the kinetics by which these
three factors induce loss of density-dependent growth
inhibition di¡er strongly [24,25], although they have
all been shown to enhance EGF receptor numbers
[26]. No direct correlation was found between the
levels of induction of known second messengers by
these three factors and their biological e¡ects to-
wards NRK cells. The observation that ET-1 induces
anchorage-independent growth of NRK ¢broblasts
[17] prompted us to compare the biological e¡ects
of ET-1 with those of PGF2K, BK and LPA in this
respect. The present data show that ET-1 is a very
potent inducer of all aspects of phenotypic transfor-
mation in NRK cells, with characteristics that are
clearly di¡erent, however, from those of the other
above ligands of G-protein-coupled receptors.
2. Materials and methods
2.1. Cell cultures
NRK cells (clone 49F) were plated at a density of
1.0U104 cells/cm2, and grown for 96 h in 24-well
tissue culture dishes until con£uence in Dulbecco’s
modi¢ed Eagle’s medium (DMEM; Gibco Life Tech-
nologies, Breda), supplemented with 10% newborn
calf serum (Hyclone, Logan, UT, USA). Con£uent
cells were subsequently made quiescent by incubation
in serum-free medium (SF) consisting of a 1:1 mix-
ture of DMEM and Ham’s F-12 medium, supple-
mented with 30 nM Na2SeO3 and 10 Wg/ml human
transferrin (Sigma, St. Louis, MO, USA) for 3 days
[27].
2.2. Growth stimulation assays
Quiescent cells were stimulated for 22 h with the
indicated factors in the presence or absence of 5 ng/
ml EGF, together with 5 Wg/ml insulin. Incorpora-
tion of [3H]thymidine (0.5 WCi/ml added; Amersham
International) was measured between 1 and 22 h
after the addition of EGF, as described [28].
2.3. Pretreatment assays
Alternatively, quiescent NRK cells were pretreated
for 8 h with the indicated factors. Subsequently the
medium was replaced by fresh SF medium without
factors and the cells were restimulated to proliferate
by the addition of 5 ng/ml EGF and 5 Wg/ml insulin.
Incorporation of [3H]thymidine (0.5 WCi/ml added)
was measured between 1 and 16 h after the addition
of EGF [26].
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2.4. Prevention of density-dependent growth inhibition
Quiescent NRK cells were stimulated for 45 h with
the indicated factors in the presence of 5 Wg/ml in-
sulin and incorporation of [3H]thymidine (0.5 WCi/ml
added) was measured between 43 and 45 h after
stimulation [27].
2.5. Restimulation of density-arrested cells
Quiescent NRK cells were stimulated for 48 h with
5 ng/ml EGF and 5 Wg/ml insulin to undergo an
additional cell cycle after which the cells become
quiescent as a result of density-arrest. Density-ar-
rested cells thus obtained were restimulated to pro-
liferate by addition of the indicated factors. The ca-
pacity of these growth factors to induce phenotypic
transformation was determined by the measurement
of [3H]thymidine incorporation (0.5 WCi/ml added),
either in a cumulative manner between 2 and 19 h
after the addition of the factors, or in successive 2-h
pulse intervals between 10 and 30 h after the addition
of the factors.
2.6. MTT assay for anchorage-independent growth
Tissue culture 96-well plates were coated with poly
(2-hydroxyethyl/methacrylate), abbreviated as poly-
(HEMA), in ethanol (Aldrich-Chemie, Deisenhofen,
Germany) as described by Fukazawa et al. [29]. One
day before each experiment, con£uent NRK cell cul-
tures were trypsinized and replated at 50% con£u-
ence in order to obtain a subcon£uent, proliferating
culture. The next day, cells were trypsinized again
and seeded in an amount of 1.5U104 cells in a vol-
ume of 130 Wl per well in SF medium supplemented
with 5 Wg/ml insulin, 0.2% bovine serum albumin
(BSA), and 10% growth factor-inactivated fetal calf
serum [28]. Subsequently, growth factors to be tested
were added to the cells in 20 Wl binding bu¡er
(DMEM supplemented with 0.1% BSA and 50 mM
Bes, pH 6.8; see [28]). After incubation for 7 days, 15
Wl MTT (5 mg/ml in phosphate-bu¡ered saline
(PBS); Sigma) was added and the cells were incu-
bated for 4 h. The produced MTT formazan was
solubilized by addition of 100 Wl of SDS solution
(20% sodium dodecyl sulfate in 0.1 M HAc), and
the absorbance was measured after 24 h at 570 nm,
relative to the absorbance at 690 nm, using a micro-
plate reader [29].
2.7. EGF-binding studies
Density-arrested NRK cells in 6-well tissue culture
dishes (9.6 cm2) were treated for 24 h with the in-
dicated factors. After washing the cells three times
with binding bu¡er, the medium was changed for 0.5
ml of binding bu¡er now containing 4 ng/ml murine
[125I]EGF (gift from Dr. T. Benraad, Department of
Endocrinology, University of Nijmegen). Nonspeci¢c
binding was determined by a parallel treatment with
a 100-fold excess of unlabeled EGF. The cells were
incubated for 1 h at room temperature after which
they were washed three times with PBS containing
0.1% BSA, three times with PBS, and subsequently
extracted with 1% Triton X-100, prior to Q-counting
[24].
2.8. Intracellular Ca2+ measurements
For calcium measurements, cells were grown on
gelatin-coated glass coverslips and cultured as de-
scribed above. Density-arrested cells were loaded
for 30 min with 2 WM Fura-2AM (Molecular Probes,
Eugene, OR, USA) in bicarbonate-bu¡ered SF me-
dium at 37‡C. Subsequently the cells were washed
and incubated in Hepes/bicarbonate-bu¡ered saline
(in mM: 145 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10
glucose, 15 Hepes, 17.6 NaHCO3) at 25‡C. Intracel-
lular calcium measurements were performed using a
spectro£uorimeter (SPF-500 Aminco) at an excita-
tion wavelength of 340 nm (4 nm bandwidth) and
an emission wavelength of 480 nm (8 nm band-
width). Growth factors were added directly to the
incubation medium [25].
2.9. Membrane potential measurements
During whole-cell patch-clamp studies, cells were
perfused at a rate of 1^2 ml per min with bicarbon-
ate-bu¡ered SF medium (5% CO2) at room temper-
ature. SF-medium contains the following concentra-
tions of inorganic salts (in mM): 109.5 NaCl, 5.4
KCl, 1.8 CaCl2, 0.81 MgCl2, 44.0 NaHCO3, and
1.0 NaH2PO4. Current clamp methods were used to
measure membrane potential. Pipettes were ¢lled
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with a high K, Tris-bu¡ered solution (in mM: 25
NaCl, 120 KCl, 1 CaCl2, 1 MgCl2, 10 Tris, 3.5
EGTA; pH 7.4). An EPC-7 patch clamp ampli¢er
(List, Darmstadt, Germany) and CED software
(Cambridge Electronic Design, Cambridge, UK)
were used to acquire data. Acquisition was obtained
at a rate of 1 Hz [30].
2.10. [3H]Arachidonic acid release
Density-arrested NRK cells in 6-well dishes were
labeled with 0.25 WCi/ml [3H]arachidonic acid (120
Ci/mmol, NEN Life Science Products International)
for 16 h. After labeling, the medium was replaced by
2 ml serum-free medium with additional 0.1% fatty
acid free BSA (Sigma). During the following 3 h the
medium was replaced every hour to remove unincor-
porated label. Factors to be tested were added for 1 h
after which total radioactivity released into 0.5 ml of
the culture medium was determined by liquid scin-
tillation analysis [25].
2.11. Inositol phosphate determination
Con£uent NRK cultures were labeled with
[3H]inositol (Amersham) as described by A¢nk et
al. [25]. After the cells had been grown to density-
arrest, they were stimulated for 30 min with the in-
dicated factors, and the formed inositol phosphates
were determined following anion-exchange chroma-
tography [25,31].
2.12. Materials
Transforming growth factor L1 (TGFL1) was from
RpD Systems Europe (Abingdon, UK). Bradykinin
(BK), lysophosphatidic acid (LPA), prostaglandin
F2K (PGF2K), and retinoic acid (RA) were from Sig-
ma. Endothelin-1 (ET-1) was from Peninsula Labo-
ratories Europe (Merseyside, UK).
3. Results
3.1. ET-1 has no mitogenic activity by itself but
enhances EGF-induced proliferation
In order to investigate the mitogenic activity of
ET-1 for NRK cells, we measured if ET-1 was able
to stimulate serum-free quiescent cells to proliferate
and compared its ability with that of LPA, BK and
PGF2K. Fig. 1A shows that BK and ET-1 have no
signi¢cant growth stimulatory activity, while in con-
trast PGF2K is slightly mitogenic and LPA is almost
as strong a mitogen as EGF. The results of stimula-
tion with LPA, BK, and PGF2K are in accordance
with those of A¢nk et al. [25].
We previously showed that EGF receptor levels
limit EGF-induced proliferation in NRK cells made
quiescent by serum deprivation and that pretreat-
ment with factors that increase EGF receptor levels
increases EGF-induced proliferation [26]. In the
present study the cells were pretreated for 8 h with
ET-1, LPA, BK, PGF2K, RA, or TGFL ; subse-
quently the factors were removed and the cells were
incubated in EGF-containing medium for 16 h dur-
ing which thymidine incorporation was measured.
Pretreatment for 8 h with ET, BK, PGF2K, RA,
Fig. 1. Mitogenic activity of ET-1; comparison with LPA, BK,
PGF2K, RA, and TGFL. (A) Serum-deprived, quiescent NRK
cells were treated for 22 h with 0.1 WM ET-1, 100 WM LPA,
1 WM BK, 1 WM PGF2K, 5 ng/ml EGF, or no addition (Cont),
in the presence of 5 Wg/ml insulin. Cumulative [3H]thymidine
(TdR) incorporation was measured between 2 and 22 h after
growth factor addition. (B) Quiescent NRK cells were pre-
treated for 8 h with 0.1 WM ET 1, 100 WM LPA, 1 WM BK,
1 WM PGF2K, 50 ng/ml RA, 1 ng/ml TGFL, or no addition
(Cont). Subsequently the medium was replaced by fresh serum
free medium and 5 ng/ml EGF and 5 Wg/ml insulin were added.
Cumulative [3H]thymidine (TdR) incorporation was measured
between 1 and 16 h after stimulation. Indicated standard errors
of the mean are based on triplicate experiments.
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and TGFL without subsequent addition of EGF did
not result in signi¢cant growth stimulation; only
LPA had strong stimulatory activity under these con-
ditions (data not shown). The data in Fig. 1B show
that pretreatment with ET-1, LPA, BK, or PGF2K
increased EGF-induced proliferation, although to a
lesser extent than following TGFL and RA pretreat-
ment. From these results it can be concluded that
ET-1 has no mitogenic activity towards NRK cells
but increases EGF-induced proliferation, indicating
that the lack of mitogenic activity is not the result
of the absence of speci¢c ET-1 receptors.
3.2. ET-1 induces phenotypic transformation of NRK
cells
Kusuhara et al. [17] showed that ET-1 is able to
stimulate anchorage-independent cell growth of
NRK cells in the presence of EGF, indicating that
ET-1 has transforming activity. Two other aspects of
phenotypic transformation of NRK cells are the loss
of density-dependent growth inhibition and the pre-
vention of density-dependent growth arrest. To study
the ability of ET-1 to induce loss of density-depend-
ent growth inhibition, NRK cells were made growth-
arrested by incubation with EGF, and cumulative
thymidine incorporation was subsequently measured
during the ¢rst 19 h following addition of the mod-
ulating factors indicated. Fig. 2A shows that ET-1 is
able to restimulate density-arrested NRK cells to al-
most the same extent as RA or TGFL. The e¡ect
induced by ET-1 was also similar to that of LPA,
but signi¢cantly stronger than that of BK or PGF2K.
We also examined if ET-1 could prevent cells from
undergoing density-arrest, by measuring
[3H]thymidine incorporation into quiescent NRK
cells between 43 and 45 h after stimulation with var-
ious factors, both in the absence and presence of
EGF, according to the protocol of Van Zoelen et
al. [27]. Fig. 2B shows that in the presence of EGF
alone, cells undergo density-dependent growth arrest,
while in the additional presence of ET-1, LPA, BK,
Fig. 2. ET-1 induces phenotypic transformation of NRK cells.
(A) Restimulation of density-arrested cells. Density-arrested
NRK cells were restimulated to proliferate by addition of 0.1
WM ET-1, 100 WM LPA, 1 WM BK, 1 WM PGF2K, 50 ng/ml
RA, 1 ng/ml TGFL, or no addition (Cont). Cumulative
[3H]thymidine (TdR) incorporation was measured between 2 and
19 h after growth factor addition. (B) Prevention of density-
dependent growth inhibition. Quiescent NRK cells were treated
for 45 h with 0.1 WM ET-1, 100 WM LPA, 1 WM BK, 1 WM
PGF2K, 50 ng/ml RA, 1 ng/ml TGFL, or no addition (Cont), in
the presence of 5 Wg/ml insulin and in the presence (hatched
bars) or absence (open bars) of 5 ng/ml EGF. Cumulative
[3H]thymidine (TdR) incorporation was measured 43^45 h after
stimulation. Indicated standard errors of the mean are based on
triplicate experiments.
Fig. 3. ET-1 induces anchorage-independent cell growth of
NRK cells. NRK cells were seeded on poly(HEMA)-coated
dishes in the presence of 0.1 WM ET-1, 100 WM LPA, 1 WM
BK, 1 WM PGF2K, 50 ng/ml RA, or 1 ng/ml TGFL, in the pres-
ence of 5 Wg/ml insulin and in the presence (hatched bars) or
absence (open bars) of 5 ng/ml EGF. After incubation for
7 days, the extent of MTT reduction during 4 h was measured
and plotted as -fold stimulation relative to untreated cells. Indi-
cated standard errors of the mean are based on quadruplicate
experiments.
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PGF2K, RA, or TGFL the cells are prevented from
undergoing density-dependent growth arrest and
keep proliferating. RA and TGFL prevent density-
arrest strongly, while ET-1, BK, LPA, and PGF2K
show lower activity in this assay. In the absence of
EGF, only LPA had signi¢cant stimulating activity.
From these results, it can be concluded that ET-1,
similar to LPA, BK, and PGF2K, prevents EGF-
treated cells from undergoing density-dependent
growth arrest. These results con¢rm that ET-1 is a
strong inducer of phenotypic transformation in NRK
cells.
3.3. ET-1 is a potent inducer of anchorage-
independent cell growth of NRK cells
Because ET-1 can induce soft agar growth of
NRK cells in serum containing medium [17], we
wondered if ET-1 can also induce cell proliferation
on poly(HEMA)-coated dishes [29] in the absence of
serum growth factors in the presence of growth-fac-
tor de¢ned medium. As can be seen in Fig. 3, ET-1 is
a potent inducer of anchorage-independent cell
growth of NRK cells in the presence of EGF, and
stimulates proliferation to almost the same extent as
PGF2K and TGFL. LPA and BK induce anchorage-
independent cell growth to a much lesser extent
under these conditions. In the absence of EGF,
only PGF2K and TGFL show some ability to induce
anchorage-independent cell growth. These results
show that ET-1 is particularly a strong inducer of
this aspect of phenotypic transformation of NRK
cells.
3.4. Kinetics of ET-1-induced phenotypic
transformation of NRK cells
The previous results show that ET-1 is a poor
mitogen for NRK cells, but a strong inducer of phe-
notypic transformation. A¢nk et al. [25] showed that
LPA induces loss of density-arrest of NRK cells with
faster kinetics than BK and PGF2K. Because ET-1
resembles LPA in its ability to overcome density-ar-
rest (Fig. 2A), we compared the kinetics by which
ET-1 restimulates density-arrested NRK cells with
the other factors by measuring [3H]thymidine incor-
poration during 2-h pulses. Fig. 4 shows that the
kinetics of the ET-1- and LPA-induced loss of den-
sity-arrest are comparable with those of RA and
Fig. 5. E¡ect of ET-1 on [125I]EGF binding to NRK cells. Se-
rum-deprived, quiescent NRK cells were treated for 8 h (open
bars) or 24 h (hatched bars) with 0.1 WM ET-1, 100 WM LPA,
1 WM BK, 1 WM PGF2K, 50 ng/ml RA, 1 ng/ml TGFL, or no
addition (Cont). [125I]EGF (4 ng/ml) binding was determined
and corrected for nonspeci¢c binding (obtained by the addition-
al treatment with a 100-fold excess of unlabeled EGF), and
plotted as -fold stimulation relative to untreated cells. Indicated
standard errors of the mean are based on at least sextuplicate
experiments.
Fig. 4. Kinetics of ET-1-induced phenotypic transformation of
NRK cells. Density-arrested NRK cells were restimulated to
proliferate by addition of 0.1 WM ET-1, 100 WM LPA, 1 WM
BK, 1 WM PGF2K, 50 ng/ml RA, or 1 ng/ml TGFL.
[3H]Thymidine (TdR) incorporation was measured in successive
2-h pulse intervals between 10 and 30 h after the addition of
the factors, and plotted as -fold stimulation relative to un-
treated cells.
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TGFL, but clearly faster than those of BK and
PGF2K, suggesting that the mechanisms by which
ET-1- and LPA induce phenotypic transformation
di¡er from those of BK and PGF2K. This di¡erence
in kinetics explains in part the low stimulation levels
observed after stimulation by BK or PGF2K for 19 h,
as shown in Fig. 2A.
3.5. E¡ect of ET-1 on [125I]EGF binding to NRK
cells
We showed previously that factors that induce
phenotypic transformation of NRK cells in an
EGF-dependent manner are also able to increase
EGF receptor numbers in these cells. Furthermore,
we showed that EGF receptor levels limit EGF-in-
duced proliferation in NRK cells made quiescent by
serum deprivation, and that pretreatment with fac-
tors that increase EGF receptor levels results in
EGF-induced proliferation [26]. ET-1 increases the
EGF-induced mitogenic activation of NRK cells
(Fig. 1B) and induces phenotypic transformation
only in the presence of EGF (Fig. 2), which suggests
that the fast induction of phenotypic transformation
by ET-1 could probably result from an increase of
EGF-receptor numbers per cell.
It is well established that an increase of [125I]EGF
binding by TGFL or inositol^lipid degrading stimuli
can be preceded by an initial decrease [26,32^34]
which is abolished after approximately 4 to 8 h
[26,32,33]. Fig. 5 demonstrates that 8 h after the
addition of ET-1, LPA, or BK, the [125I]EGF bind-
ing is not signi¢cantly di¡erent from the starting lev-
el, while 8 h after the addition of PGF2K a decrease is
indeed observed. At this time point, the RA- and
TGFL-induced [125I]EGF binding is already strongly
increased. Incubation of density-arrested NRK cells
for 24 h, however, with ET-1, LPA, BK, or PGF2K
results in a signi¢cant increase in binding although
both TGFL and RA remain much more potent stim-
ulators of EGF binding. Concluding, it can be stated
that phenotypic transformation is induced by these
Fig. 6. ET-1 induces Ca2-mobilization in NRK cells. (A) Typical Ca2 responses to the addition of 0.1 WM ET-1 (1), 100 WM LPA
(2), 1 WM BK (3) or 1 WM PGF2K (4) to density-arrested NRK cells. (B) Ca2 responses to a second dose of ET-1 (1) or BK (2) and
to the subsequent addition of BK (1) or ET-1 (2). Ca2 levels are represented as Fura-2 £uorescence intensities. Each trace is repre-
sentative of at least ¢ve similar experiments.
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factors only in the presence of EGF and that this
phenotypic transformation is accompanied by an in-
crease in the EGF receptor numbers, suggesting that
such increase is a prerequisite for phenotypic trans-
formation.
3.6. ET-1 is a strong inducer of Ca2+-release
To ¢nd a possible cause for the di¡erences in the
kinetics by which ET-1, LPA, BK and PGF2K induce
phenotypic transformation of NRK cells, we inves-
tigated the production of second messengers after
stimulation with these factors. In NRK cells, ET-1
has been shown to bind to ETA receptors [18] result-
ing in an increase in [Ca2]i[17,19]. In Fig. 6A it is
shown that ET-1, LPA, BK and PGF2K all induce a
transient increase in intracellular Ca2 with compa-
rable kinetics. However, Fig. 6B shows that upon
repetitive addition of various ligands, ET-1 not
only induces homologous desensitization, but also
heterologous desensitization towards BK (and LPA
or PGF2K ; data not shown). In contrast, BK induces
only homologous desensitization but no heterologous
desensitization towards ET-1. PGF2K and LPA be-
haved similar as BK, in that they induced homolo-
gous but no heterologous desensitization (data not
shown). Another striking feature of ET-1 which is
not shared by the three other ligands of G-protein-
coupled receptors is the sustained increase in intra-
cellular Ca2 it induces. This phenomenon has also
Fig. 7. ET-1 induces prolonged membrane depolarization in monolayers of NRK cells. Typical depolarization in response to 0.1 WM
ET-1, 100 WM LPA, 1 WM BK, or 1 WM PGF2K measured in the current clamp mode of the whole-cell patch-clamp con¢guration.
Cells were continuously perfused and the agonists were included in the perfusion medium during the indicated time. Each trace is rep-
resentative of at least ¢ve similar experiments.
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been observed in Swiss 3T3 ¢broblasts [35], and most
likely results from the quasi-irreversible nature of
endothelin binding to its receptor, causing a pro-
longed activation of its G protein-linked signaling
pathways [36]. These data show that with respect
to the ability to induce cellular Ca2 responses (mo-
bilization) ET-1 behaves di¡erently from the other
three ligands.
3.7. ET-1 induces prolonged membrane depolarization
The e¡ect of ET-1 on membrane potential was
investigated using whole-cell patch-clamp measure-
ments in the current clamp mode. The cells were
continuously perfused and the agonists were included
in the perfusion medium during the indicated time
periods (approximately 5 min). Fig. 7 shows that
ET-1, LPA, BK and PGF2K caused a rapid depolar-
ization of the membrane in density-arrested NRK
cells. This correlates with the results of De Roos et
al. [30] on BK- and PGF2K-induced depolarization as
a result of the opening of a calcium-dependent chlo-
ride channel. Upon removal of the ligands, however,
a rapid repolarization was observed in the case of
LPA, BK and PGF2K, but not in the case of ET-1.
These observations are in line with the notion that
ET-1 may bind its receptor in a quasi-irreversible
manner, resulting in prolonged receptor activation
[36,37].
3.8. ET-1 is a strong inducer of [3H]arachidonic acid
release and phosphatidylinositol diphosphate
hydrolysis
Activation of G-protein-coupled receptors may re-
sult in the induction of arachidonic acid (AA) release
and hydrolysis of phosphatidylinositol diphosphate
(PtdIns(4,5)P2). Fig. 8A shows that after 1 h of stim-
ulation LPA and BK stimulate AA-release only
weakly, while PGF2K and particularly ET-1 are
stronger inducers. Fig. 8B shows that ET-1 is also
by far the strongest inducer of PtdIns(4,5)P2 hydrol-
ysis in these cells, with twofold higher induction than
PGF2K. Although ET-1 and PGF2K induce
PtdIns(4,5)P2 hydrolysis much stronger than BK
and LPA, the data of Fig. 6A show that this does
not necessarily have to result in a more e⁄cient
Ca2-release. Although our present and previous re-
sults [25] show that there is no direct correlation
between the levels of second messenger generation
and the ability of ligands to induce phenotypic trans-
formation, the results presented in Figs. 6^8 indicate
that of all ligands tested, ET-1 is by far the strongest
inducer of second messengers in NRK cells.
4. Discussion
In the present study, we have shown that ET-1 is a
strong transforming factor for NRK cells with char-
acteristics di¡erent from those of the other G-pro-
tein-coupled receptor activating factors investigated.
To summarize, ET-1 has no mitogenic activity in the
absence of other growth factors, it increases EGF-
induced proliferation, it induces phenotypic transfor-
mation in an EGF-dependent manner and with fast
kinetics, it increases [125I]EGF binding to NRK cells,
Fig. 8. ET-1 is a strong inducer of [3H]arachidonic acid (AA)
release and PtdIns(4,5)P2 hydrolysis. (A) AA-release. Density-
arrested, [3H]arachidonic acid-labeled NRK cells were stimu-
lated for 1 h with 0.1 WM ET-1, 100 WM LPA, 1 WM BK, or
1 WM PGF2K, after which total radioactivity released into 0.5 ml
of the culture medium was determined by liquid scintillation
analysis and plotted as -fold stimulation relative to untreated
cells. Indicated standard errors of the mean are based on at
least quintuplicate experiments. (B) PtdIns(4,5)P2 hydrolysis.
Density-arrested, [3H]inositol-labeled NRK cells were stimulated
for 30 min with 0.1 WM ET-1, 100 WM LPA, 1 WM BK, or
1 WM PGF2K, after which the inositol phosphates were deter-
mined and plotted as -fold stimulation relative to untreated
cells. Indicated standard errors of the mean are based on tripli-
cate experiments.
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it is a strong inducer of AA-release and PtdIns(4,5)P2
hydrolysis, and it induces a Ca2 transient and a
rapid depolarization of the membrane. Typically,
the addition of ET-1 leads to a prolonged depolari-
zation of the membrane and prevents Ca2-mobiliza-
tion by the other ligands of G-protein-coupled recep-
tors. ET-1, as well as PGF2K, LPA and BK, induces
a transient increase in intracellular Ca2 in Swiss 3T3
¢broblasts, despite the fact that these cells already
exhibit a depolarized membrane (around 330 mV)
compared to NRK cells (Theuvenet et al., unpub-
lished). This makes unlikely that the prolonged de-
polarization of NRK cells is responsible for the ho-
mologous and heterologous desensitization of
cellular Ca2 responses by ET-1.
When the characteristics of ET-1 are compared
with those of PGF2K, LPA, and BK, it can be seen
that only LPA is mitogenic in the absence of other
growth factors. All of these factors induce pheno-
typic transformation, a Ca2 transient and a rapid
depolarization of the membrane, and increase
[125I]EGF binding to NRK cells. However, BK and
PGF2K induce phenotypic transformation with de-
layed kinetics and LPA and ET-1 with fast kinetics.
There are also large di¡erences in the levels of second
messengers induced: ET-1 and PGF2K induce very
strong PtdIns(4,5)P2 hydrolysis and are both strong
inducers of AA-release, while LPA and BK do so
with much less potency. Only ET-1 induces a pro-
longed depolarization of the membrane and only the
transient enhancement of intracellular calcium con-
centration by ET-1 is parallelled by heterologous de-
sensitization.
Various cell types have been tested and those stud-
ies show that ET-1 can activate Gq [4^7], Gi [4,8,9]
and Gs [10]. In comparison, PGF2K has been shown
to activate Gq, leading to the activation of the phos-
pholipase CL pathway [21,38,39], and the increase of
protein tyrosine kinase activity [38,40]. BK activates
Gq [41,42] and Gs [41] resulting in the activation of
adenylate cyclase. LPA activates Gq [23], Gs [43],
and Gi [23], which leads to the inhibition of adenyl-
ate cyclase and the activation of Ras [44], while it
can also activate phosphatidylinositol 3-kinase [23].
Furthermore, BK, LPA, and ET-1 can activate phos-
pholipase A2 [1,23,41] via a still unknown G protein
or indirectly via Gq [45,46]. They all activate phos-
pholipase D [5,7,23,40,47] also via a still unknown G
protein or indirectly via Gq [45]. Our present results,
together with previous results from this laboratory
[24,25], show that also in NRK cells these factors
induce degradation of inositol-containing phospho-
lipids, release of arachidonic acid (AA), and mobili-
zation of Ca2, all indicative for activation of phos-
pholipase C and phospholipase A2, most likely
mediated by activation of Gq. However, activation
of phospholipase A2 can also take place by other
mechanisms (for reviews see [45,46]), which could
explain the present observation that apparently there
is no correlation between the potency of factors to
induce AA-release and to hydrolyze PtdIns(4,5)P2.
Our results show that, in spite of their di¡erent
biological e¡ects on NRK cells, the four explored
agonists induce the same second messengers, how-
ever the absolute levels are di¡erent. It is possible
that the studied signaling pathways are only neces-
sary but not su⁄cient for phenotypic transformation,
and that activation of additional pathways is essen-
tial. Several other reports suggest that in addition to
the activation of the (Gq-induced) PLC pathway,
additional pathways have to be activated to induce
a mitogenic response (reviewed by [48]). For exam-
ple, the mitogenic action of LPA is believed to be
mediated by activation of Gi [23,44,49,50], leading to
a decrease in cyclic AMP levels. In several other cell
types ET-1 also activates this G protein [4,8,9]. How-
ever, we could only detect a decrease in forskolin-
stimulated cyclic AMP levels in NRK cells upon
treatment with LPA, similar to previous results
[25], but not upon stimulation with ET-1, BK of
PGF2K. The latter two agents even increased cyclic
AMP levels in these cells (data not shown). However,
in Swiss 3T3 cells ET-1 induces Gi similar to LPA
and is mitogenic in the absence of other growth fac-
tors [4], suggesting that activation of Gi correlates
with the direct mitogenic activity of a factor. Fur-
thermore, it has been suggested that not the absolute
amount of second messengers, but much more the
kinetics of their induction are important for the bio-
logical action of an agonist [7]. The fact that the
most factors tested here activate the same pathways
but have di¡erent biological e¡ects supports this no-
tion. In addition, other second messenger systems
such as phospholipase D activation, sphingomyelin
degradation [51], activation of phosphatidylinositol
(PI)-3-kinase [52], and enhancement of nitric oxide
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or cyclic GMP [53] could also be of relevance to
understand the biological activity of the factors
tested, while it cannot be excluded that other, still
unknown, pathways activated by G-protein-coupled
receptors are involved. We showed that ET-1 induces
a prolonged depolarization of the membrane and
prevents Ca2-mobilization by the other ligands of
G-protein-coupled receptors as a result of heterolo-
gous desensitization. These observations are in line
with previous studies showing that ET-1 may bind its
receptor in a quasi-irreversible manner [36,37]. This
phenomenon could explain the fast kinetics by which
ET-1 induces phenotypic transformation and the
strong induction of second messengers.
We have previously postulated [20] that NRK cells
become density-arrested as a result of decreased EGF
receptor levels and become phenotypically trans-
formed by factors that increase EGF receptor levels,
thereby enhancing the growth-stimulating signals in-
duced by EGF. It has been shown that in NRK cells
ET-1 complements EGF to induce cell proliferation
[16], and that ET-1 upregulates EGF receptor num-
bers [18]. Together with our present results, this sug-
gests that the observed increase in EGF receptor lev-
els upon ET-1 treatment is essential for induction of
phenotypic transformation of NRK cells. However,
our present results also show that ET-1 induces this
process with similar fast kinetics as LPA, RA and
TGFL, while BK and PGF2K appear to act much
slower. The fast induction of loss of density-arrest
by RA and TGFL can be rationalized by their rapid
enhancement of EGF receptor levels (Fig. 5), while
LPA not only enhances EGF receptor levels but is
also mitogenic by itself. However, the rate by which
ET-1 enhances EGF receptor levels does not appear
to be much di¡erent from BK and PGF2K, in spite of
their di¡erent kinetics in inducing transformation.
So, although enhancement of EGF receptor levels
seems essential for induction of phenotypic transfor-
mation of NRK cells, no direct correlation could be
observed between the kinetics of both processes. In
this respect it should be realized that BK is also
known to transiently induce an inhibitor of pheno-
typic transformation [25,54] while under certain con-
ditions PGF2K appears to have similar inhibitory ac-
tivity (not shown). This could explain the delayed
induction of phenotypic transformation despite the
strong induction of second messengers.
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